20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Evaluating the effectiveness of treatments using trial emulation
This epidemiological, or population, study will use existing medical databases to assess whether three repurposed drugs affect the incidence rate and progression of Parkinson’s. Contents About the study Clinical trials are a necessary step in the drug approval process; however, they are often difficult to...
Exenatide-PD3: Exenatide and Parkinson’s
The Exenatide-PD3 study was a phase 3 clinical trial of Type 2 diabetes drug exenatide (Bydureon) which finished in early 2024. The results of this trial have now been published and they indicate that the study did not slow the progression of Parkinson’s compared to...